Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

ImmunoGen, Inc. (IMGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.7800+0.0800 (+1.70%)
At close: 04:00PM EDT
4.5900 -0.19 (-3.97%)
After hours: 07:16PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close4.7000
Open4.7600
Bid4.5900 x 3000
Ask5.0100 x 2900
Day's Range4.7400 - 4.9900
52 Week Range3.1000 - 7.7700
Volume2,101,996
Avg. Volume2,974,558
Market Cap1.055B
Beta (5Y Monthly)0.90
PE Ratio (TTM)N/A
EPS (TTM)-0.5890
Earnings DateOct 27, 2022 - Oct 31, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.21
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for IMGN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ImmunoGen, Inc.
    Analyst Report: AbbVie Inc.AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more
Advertisement
Advertisement